Tianjin Lisheng Pharmaceutical Co., Ltd. (stock code 002393) was founded in 1951 and is a pharmaceutical company that has grown up with the pace of industrial revitalization in New China. Over the past few decades, the company has been widely praised by the society for producing high-quality drugs to serve human health, and has made positive contributions to my country's medical and health industry.

The company now has two wholly-owned subsidiaries: Tianjin Central Pharmaceutical Co., Ltd. (hereinafter referred to as "Central Pharmaceutical"), and Tianjin Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as "Biochemical Pharmaceutical"). It has four shareholders: Tianjin Pharmaceutical Group Finance Co., Ltd., Tianjin Tianbian Pharmaceutical Co., Ltd., Tianjin Leduan Traditional Chinese Medicine Co., Ltd., and Tianjin Pharmaceutical Group Marketing Management Co., Ltd. Central Pharmaceutical, wholly-owned subsidiary, has a stake in Tianshili Holding Group Co., Ltd.

The company has been recognized as a national high-tech enterprise and a national green factory. The products cover 15 categories, with a total of 243 drug approval numbers, involving Chinese and Western medicine tablets, capsules, oral liquids, granules, biological preparations and raw materials. The marketing network covers the whole country, and some products are sold all over the world. Among them, core products such as "Shoubishan" brand indapamide tablets, "Shifoni" brand cefdinir dispersed tablets, marin soft capsules, and nardeparin calcium injection have gained high market recognition.

Lisheng people have always adhered to the professional philosophy of "being good people and making good medicine", focusing on cardiovascular, anesthesia and analgesics, mental, anti-infection, anti-diabetics, and nourishing. They continue to innovate in important therapeutic areas such as continuous treatment, and continuously improve human beings. Quality of life. In the future, the company will firmly focus on the development path of high-quality innovation and upgrading of its main business, maintain strategic determination, strengthen development confidence, stick to its goals and not relax, forge ahead, and be ahead of advanced pharmaceuticals with core competitiveness, industry influence and international capabilities. The company's development goals are moving forward, making Lisheng Company an excellent pharmaceutical company worthy of the trust of patients.